Qing Nian, a partner in Goodwin’s Technology + Life Sciences Group, focuses her practice on corporate and securities law. She represents public and private companies, venture capital and private equity firms, and investment banks in capital markets transactions, mergers and acquisitions, venture capital financings, SEC reporting, and other general corporate and securities matters. Ms. Nian advises companies through every stage of the corporate lifecycle – from initial financing through successful initial public offering or acquisition.

Prior to joining Goodwin in 2010, Ms. Nian was a Public Interest Fellow at Medical-Legal Partnership | Boston, where she provided pro bono legal services to low-income families.

While attending Washington University in St. Louis, Ms. Nian was a McDonnell Scholar at the McDonnell International Scholars Academy.

Experience

ERFAHRUNG

工作经历

Ms. Nian’s recent work includes representing:

  • AMRI in its $358 million acquisition of Euticals
  • Atlantic Power in its $1 billion cross-border acquisition of Capital Power Income and related financings
  • Allena Pharmaceuticals in its $53 million Series C financing
  • BeiGene in its $75 million Series A financing, $97 million Series A-2 financing, $160 million U.S. IPO and $200 million follow-on offering
  • Caliber I.D. in a range of securities law and other matters
  • Courier Corporation in its acquisition of FastPencil, Inc.
  • DBV Technologies in its $133 million global offering and U.S. IPO
  • DST Global in its investments in China
  • Explorica in its sale to WorldStrides
  • Fleetmatics in its $2.4 billion sale to Verizon
  • Galapagos in its $275 million global offering and U.S. IPO
  • Hillhouse Capital in its various investments
  • Neos Therapeutics in its $75 million IPO
  • TA Associates in its investments in the U.S. and China
  • TripAdvisor in a range of securities law matters and acquisitions
  • UniFirst Corporation in a range of securities law matters and acquisitions
  • Zafgen in its IPO and follow-on offering
  • Lead Investor in its investment in Xiaomi Corporation
  • Various U.S. domestic issuers and foreign private issuers in their SEC filings

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2009
Washington University School of Law
LL.M., 2007
Washington University School of Law
LL.M., 2006
University of Hong Kong
LL.B., 2005
Tsinghua University

Admissions

Bar

Massachusetts
New York
Registered Foreign Lawyer, Hong Kong SAR

Languages

Sprachen

语言

English
Mandarin
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师